"I realize we're close to beer time here -- promise to at least give you something very scintillating." -- Paul Richardson, MD, of the Dana-Farber Cancer Institute in Boston, before...

LONDON -- Late-breaking abstracts presented at the European Alliance of Associations for Rheumatology's (EULAR) annual meeting, held here last week, addressed a wide range of clinical concerns and suggested that...

NEW ORLEANS -- Petrelintide, an investigational long-acting amylin analog, induced significant weight loss with minimal side effects in the global phase II ZUPREME-1 study. By week 28, all five investigational...

Full results from two Lilly trials of the novel triple hormone receptor agonist show reductions in A1c, osteoarthritis knee pain, and obstructive sleep apnea. Medscape Medical News Source link :...

Obesity management medications improve patients' perceived physical function and have a 'modest' impact on an objective functional measure. Medscape Medical News Source link : https://www.medscape.com/viewarticle/obesity-meds-improve-patients-perceived-physical-function-2026a1000iyv?src=rss Author : Publish date :...

Patients with obesity and type 2 diabetes have more favorable QOL outcomes taking a GLP-1 than those with either condition alone or with multiple comorbidities. Medscape Medical News Source link...

Years ago, a practice operations leader told me that every patient encounter -- no matter how urgent -- was an opportunity to capture a quality metric. She referred to this...

LONDON -- Baricitinib (Olumiant) failed to show noninferiority to tumor necrosis factor (TNF) inhibitors for venous thromboembolism (VTE) risk in FDA-required postmarketing studies, a researcher reported here. In two large...

A Cambridge-developed AI vaccine targeting shared features across coronavirus families has passed a phase I safety trial, with a phase II study now planned. Press Association Source link : https://www.medscape.com/s/viewarticle/cambridge-teams-ai-vaccine-passes-first-human-trial-2026a1000iyl?src=rss...

Share on PinterestResearch shows that eating more avocado can reduce your risk of diabetes, hypertension, and obesity. Image Credit: Anjelika Gretskaia/Getty ImagesResearch suggests that females who eat 30–38 grams of...

Fuelled by social media, the market for children's skincare is booming. Experts fear for the long-term impact on girls Source link : https://www.bbc.com/news/articles/cx212x41evwo?at_medium=RSS&at_campaign=rss Author : Publish date : 2026-06-06 23:06:00...

Patients with RA have a higher risk of blood clots and serious infections with baricitinib vs older biologics, but not heart disease or cancer, according to two safety trials. Medscape...

Cigarette smokers have a significantly lower likelihood of being diagnosed with Sjögren's disease, with histologic data showing less tissue damage and lower disease activity in smokers who have it. Medscape...

No changes in diabetic retinopathy status occurred in high-risk people with type 2 diabetes taking tirzepatide when compared with dulaglutide. Medscape Medical News Source link : https://www.medscape.com/viewarticle/no-increased-retinopathy-risk-seen-tirzepatide-2026a1000iyc?src=rss Author : Publish...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech...

Chinese herb-derived compound tetrandrine shows signs of efficacy in methotrexate-treated patients with moderate to severe rheumatoid arthritis, but placebo rates are high. Medscape Medical News Source link : https://www.medscape.com/viewarticle/tetrandrine-trialed-novel-rheumatoid-arthritis-treatment-2026a1000iya?src=rss Author...

The amylin analog petrelintide reduces body weight with 'placebo-like' tolerability, a phase 2 trial shows. Medscape Medical News Source link : https://www.medscape.com/viewarticle/petrelintide-tolerability-could-improve-glp-1-challenges-2026a1000iy7?src=rss Author : Publish date : 2026-06-06 16:21:00 Copyright...

Names matter. They shape expectations, guide behavior, and in medicine, determine how systems are built, how resources are allocated, and how clinicians practice. The name "emergency medicine" is one of...

Zemprocitinib, a next-generation JAK1 inhibitor, may tame rheumatoid arthritis that does not respond to at least one biologic disease-modifying antirheumatic drug, a phase 3 clinical trial finds. Medscape Medical News...

Low-dose naltrexone does not provide real clinical benefit for patients with fibromyalgia compared to placebo, according to a clinical trial. Medscape Medical News Source link : https://www.medscape.com/viewarticle/low-dose-naltrexone-fails-outperform-placebo-pain-2026a1000iy0?src=rss Author : Publish...